BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Engineered extracellular vesicle nanoplatform for multiplexed lysosomal protein degradation

BC Staff
June 2, 2026 9:06 PM UTC

BCIQ Target Profiles

Microtubule-associated protein 1 light chain 3 beta (MAP1LC3B) (LC3B)

BCIQ Target Profiles

Microtubule-associated protein 1 light chain 3 beta (MAP1LC3B) (LC3B)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS